236 related articles for article (PubMed ID: 29563506)
21. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.
Lohr JG; Stojanov P; Carter SL; Cruz-Gordillo P; Lawrence MS; Auclair D; Sougnez C; Knoechel B; Gould J; Saksena G; Cibulskis K; McKenna A; Chapman MA; Straussman R; Levy J; Perkins LM; Keats JJ; Schumacher SE; Rosenberg M; ; Getz G; Golub TR
Cancer Cell; 2014 Jan; 25(1):91-101. PubMed ID: 24434212
[TBL] [Abstract][Full Text] [Related]
22. Expressed fusion gene landscape and its impact in multiple myeloma.
Cleynen A; Szalat R; Kemal Samur M; Robiou du Pont S; Buisson L; Boyle E; Chretien ML; Anderson K; Minvielle S; Moreau P; Attal M; Parmigiani G; Corre J; Munshi N; Avet-Loiseau H
Nat Commun; 2017 Dec; 8(1):1893. PubMed ID: 29196615
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations.
Chng WJ; Santana-Dávila R; Van Wier SA; Ahmann GJ; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Jacobus S; Blood E; Oken MM; Henderson K; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
Leukemia; 2006 May; 20(5):807-13. PubMed ID: 16511510
[TBL] [Abstract][Full Text] [Related]
24. The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
Höllein A; Twardziok SO; Walter W; Hutter S; Baer C; Hernandez-Sanchez JM; Meggendorfer M; Haferlach T; Kern W; Haferlach C
Cancer Genet; 2020 Apr; 242():15-24. PubMed ID: 31980417
[TBL] [Abstract][Full Text] [Related]
25. Genomics of Multiple Myeloma.
Robiou du Pont S; Cleynen A; Fontan C; Attal M; Munshi N; Corre J; Avet-Loiseau H
J Clin Oncol; 2017 Mar; 35(9):963-967. PubMed ID: 28297630
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).
Kortüm KM; Langer C; Monge J; Bruins L; Zhu YX; Shi CX; Jedlowski P; Egan JB; Ojha J; Bullinger L; Kull M; Ahmann G; Rasche L; Knop S; Fonseca R; Einsele H; Stewart AK; Braggio E
Ann Hematol; 2015 Jul; 94(7):1205-11. PubMed ID: 25743686
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Bolli N; Biancon G; Moarii M; Gimondi S; Li Y; de Philippis C; Maura F; Sathiaseelan V; Tai YT; Mudie L; O'Meara S; Raine K; Teague JW; Butler AP; Carniti C; Gerstung M; Bagratuni T; Kastritis E; Dimopoulos M; Corradini P; Anderson KC; Moreau P; Minvielle S; Campbell PJ; Papaemmanuil E; Avet-Loiseau H; Munshi NC
Leukemia; 2018 Dec; 32(12):2604-2616. PubMed ID: 29789651
[TBL] [Abstract][Full Text] [Related]
28. Multiple Myeloma Genomics: A Systematic Review.
Weaver CJ; Tariman JD
Semin Oncol Nurs; 2017 Aug; 33(3):237-253. PubMed ID: 28729121
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing primary and secondary translocations in multiple myeloma.
Gabrea A; Leif Bergsagel P; Michael Kuehl W
DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
[TBL] [Abstract][Full Text] [Related]
30. [Cytogenetic and molecular basis of multiple myeloma].
Taniwaki M; Matsumoto Y
Nihon Rinsho; 2007 Dec; 65(12):2179-86. PubMed ID: 18069258
[TBL] [Abstract][Full Text] [Related]
31. Dual Primary IGH Translocations in Multiple Myeloma: A Novel Finding.
Ravindran A; Greipp PT; Wongchaowart N; Smadbeck JB; Peterson JF; Ketterling RP; Kumar SK; Baughn LB
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):e710-e713. PubMed ID: 34172422
[No Abstract] [Full Text] [Related]
32. Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas.
Otto C; Scholtysik R; Schmitz R; Kreuz M; Becher C; Hummel M; Rosenwald A; Trümper L; Klapper W; Siebert R; Küppers R;
Genes Chromosomes Cancer; 2016 Dec; 55(12):932-943. PubMed ID: 27356265
[TBL] [Abstract][Full Text] [Related]
33. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
[TBL] [Abstract][Full Text] [Related]
34. Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort.
Kanamori T; Sanada M; Ri M; Ueno H; Nishijima D; Yasuda T; Tachita T; Narita T; Kusumoto S; Inagaki A; Ishihara R; Murakami Y; Kobayashi N; Shiozawa Y; Yoshida K; Nakagawa MM; Nannya Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Horibe K; Handa H; Ogawa S; Iida S
Br J Haematol; 2020 Dec; 191(5):755-763. PubMed ID: 32386081
[TBL] [Abstract][Full Text] [Related]
35. Role of genetics in prognostication in myeloma.
Avet-Loiseau H
Best Pract Res Clin Haematol; 2007 Dec; 20(4):625-35. PubMed ID: 18070710
[TBL] [Abstract][Full Text] [Related]
36. [Advances in multiple myeloma molecular biology research].
Hanamura I
Rinsho Ketsueki; 2019; 60(9):1236-1242. PubMed ID: 31597849
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants as biomarkers for progression and resistance in multiple myeloma.
Montel RA; Gregory M; Chu T; Cottrell J; Bitasktsis C; Chang SL
Cancer Genet; 2021 Apr; 252-253():1-5. PubMed ID: 33338886
[TBL] [Abstract][Full Text] [Related]
38. [Subclassification of multiple myeloma based on the partner genes of immunoglobulin heavy chain gene translocations].
Nishida K; Taniwaki M
Rinsho Ketsueki; 2000 May; 41(5):414-7. PubMed ID: 10879102
[No Abstract] [Full Text] [Related]
39. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
[TBL] [Abstract][Full Text] [Related]
40. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
